Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review.
about
Tubal ectopic pregnancyFertility after ectopic pregnancy: the DEMETER randomized trialIncidence, diagnosis and management of tubal and nontubal ectopic pregnancies: a reviewCombination gefitinib and methotrexate treatment for non-tubal ectopic pregnancies: a case series.Evaluation of Plasma Creatine Phosphokinase (CPK) Level Following a Single Injection of Methotrexate as a Predicator of Treatment Success in Ectopic Pregnancy.Tubal ectopic pregnancy.Methotrexate for ectopic pregnancy: when and how.Ectopic pregnancy: diagnosis and management.Single-dose methotrexate treatment for ectopic pregnancy and pregnancy of unknown location and progesterone as a predictor of success.The evolution of methotrexate as a treatment for ectopic pregnancy and gestational trophoblastic neoplasia: a review.Medical management of ectopic pregnancy: a comparison of regimens.Ectopic pregnancy after infertility treatment.Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol.The Role of Plasma Creatine Phosphokinase (CPK) Level in Prediction of Response to Methotrexate for Ectopic Pregnancy.A Clinical Experience of Ectopic Pregnancies with Initial Free Intraperitoneal FluidOutcome prediction for treatment of tubal pregnancy using an intramuscular methotrexate protocol.Robot-assisted segmental resection of tubal pregnancy followed by end-to-end reanastomosis for preserving tubal patency and fertility: An initial report.Pretreatment serum human chorionic gonadotropin cutoff value for medical treatment success with single-dose and multi-dose regimen of methotrexate in tubal ectopic pregnancy.Efficacy of methotrexate therapy in patients with tubal pregnancy and a serum human chorionic gonadotropin level above 10,000 IU/L.Single-dose methotrexate injection for treatment of ectopic pregnancy in women with relatively low levels of human chorionic gonadotropin.Low-dose methotrexate treatment in ectopic pregnancy: a retrospective analysis of 164 ectopic pregnancies treated between 2000 and 2008.Safety and Efficacy of Uterine Artery Embolization in Ectopic Pregnancies Refractory to Systemic Methotrexate Treatment: A Single-Center Study.The effect of parental 5,10-methylenetetrahydrofolate reductase 677C/T and 1298A/C gene polymorphisms on response to single-dose methotrexate in tubal ectopic pregnancy.Clinical predictors of failing one dose of methotrexate for ectopic pregnancy after in vitro fertilization.Predictors of Success of a Single-Dose Methotrexate in the Treatment of Ectopic Pregnancy.Can hematologic parameters predict treatment of ectopic pregnancy?Values of beta-human chorionic gonadotrofin as a risk factor for tubal pregnancy rupture evaluated by histopathology.Predicting success of methotrexate treatment by pretreatment HCG level and 24-hour HCG increment.Interstitial pregnancy treated by transcervical aspiration of the gestational sac combined with systemic and local administration of methotrexate.Tubal PregnancyHemostatic gelatine-thrombin matrix (Floseal®) facilitates hemostasis and organ preservation in laparoscopic treatment of tubal pregnancy.Early prediction for the requirement of second or third dose methotrexate in women with ectopic pregnancy, treated with single-dose regimen.
P2860
Q27000741-3F5032EB-3DB0-4706-9F0C-EABA215200E1Q28287053-85A0DC3B-41B4-4854-BFB5-ED1D18FB160BQ33655242-60277DBE-A62E-434D-B32F-4CC266CCD90FQ33762029-1C036F18-5B80-4132-A3E8-179ED7BAFE0BQ33782936-BDAD4B2A-C966-4825-BC4C-E0FE68B1793FQ34010605-A0EB7162-D7BF-48E0-8E7C-E7C18EE93A40Q34418588-EB4989BC-7F85-4585-9BCB-C5D10CCAC683Q34601711-4C775EE7-065A-4AA7-8F0B-239FDB76BF30Q35306565-3F0CE43E-5866-4211-9E9C-FD48A3BBAD6EQ35825304-EC3BCD16-900F-4333-9C0F-A13CF99B8042Q35897736-ECD945A5-5334-43A8-A668-D5C28939C13EQ36385521-C5693838-737B-4646-BEA7-224E8F919C46Q37029975-0AFA5EBA-54F0-4CE5-8115-B6AE68069AF9Q37262635-4F64C9BF-4D13-4458-B59B-799EA2C5C7DBQ37266303-10C20946-01DA-45D6-8D69-98597BAE1725Q37276504-5920AA8A-6A57-43B6-8E90-37EB3969A553Q37354722-50BC4540-C9CD-4633-972C-3F7DFB4DD798Q37647356-A67580D3-C90A-4238-A8BD-37A83DA5D098Q37669764-7722E4C8-A0CD-47F6-8B47-C303A9A9A189Q38087049-6135906A-5777-4996-AD73-19DFE5D42348Q38126358-5E883B29-5737-4742-9B59-DC7DE4661286Q39277370-4C456A94-1F18-4A37-9A18-E7C5BAFFE243Q39630870-7D0B9172-85B2-4566-98E3-44455B5947EFQ40393438-5AE991BD-CA4F-409A-8CA5-4B872C1A4A9EQ41780408-D55D394C-363F-4FA4-AD65-3CF4E28B67A3Q42669561-F57C7A5D-2186-40ED-888E-279730FDA4FBQ43771916-5A41CD5F-8FC3-4E1D-8FD6-87075E8E4617Q47212520-1893D5AF-E13D-450F-AE5D-83F581A6D8CBQ51471663-08B11C67-65DD-4A0C-8668-6C3980A7C0EEQ53101753-C3FFE37D-240C-4C3C-8784-045D4C0025F0Q53554124-FB164E95-FEE1-4AB6-B49E-B4B6294A54A4Q53659793-E76488D3-86B5-46B0-9435-7C6B0479076C
P2860
Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Establishing a human chorionic ...... regnancy: a systematic review.
@ast
Establishing a human chorionic ...... regnancy: a systematic review.
@en
type
label
Establishing a human chorionic ...... regnancy: a systematic review.
@ast
Establishing a human chorionic ...... regnancy: a systematic review.
@en
prefLabel
Establishing a human chorionic ...... regnancy: a systematic review.
@ast
Establishing a human chorionic ...... regnancy: a systematic review.
@en
P2093
P1476
Establishing a human chorionic ...... regnancy: a systematic review.
@en
P2093
John Colins
Kurt T Barnhart
Seema Menon
P304
P356
10.1016/J.FERTNSTERT.2006.10.007
P407
P577
2006-12-14T00:00:00Z